endovascular.es

Título: ZOLL Announces Acquisition of Philips InnerCool Temperature Management
Fecha: 17-11-2014
Expands ZOLL’s Temperature Management Portfolio
November 17, 2014—CHELMSFORD, MASS.— ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has signed an agreement to purchase substantially all of the assets of Philips’ InnerCool™ temperature management business, which includes catheter-based endovascular and surface temperature management technologies designed to improve outcomes for patients with a variety of temperature management-related needs.
InnerCool’s technology includes the RTx Endovascular System, the Accutrol™ Catheter, and the CoolRepeat™ and STx Surface Cooling Systems. All four products have regulatory clearance in the United States. The acquisition provides synergy with ZOLL’s acute critical care portfolio of temperature management products.
“The combination of InnerCool with ZOLL’s existing temperature management technologies expands ZOLL’s position as the leading provider of high technology systems for precise temperature management,” said James Palazzolo, President of ZOLL. “This underscores our commitment to provide a wide variety of clinical temperature therapies based on physician preference and clinical judgment.”
The InnerCool assets also provide ZOLL with a rich patent portfolio and pipeline of future products. InnerCool will be integrated into ZOLL’s Temperature Management business in San Jose, California.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 29,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2014 ZOLL Medical Corporation. All rights reserved. ZOLL is a registered trademark of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.
Fuente: endovascular.es

endovasculares.es